Concepedia

Kenneth M. Comess

KM

Statistics

Publications

24

Citations

2.1K

H-Index

22

Active since

1990

Affiliations

Abbott (United States)(Current)

AbbVie (United States)

Abbott Fund

Massachusetts Institute of Technology

Abbott (United Kingdom)

Kenneth M. Comess is an author at Abbott (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

1990–2020

24

Publications

24

A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding

Dianne Sako, Kenneth M. Comess, K.M. Barone et al. · Cell · 1995 · 440 citations · Full text

, , +12

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin et al. · Nature Chemical Biology · 2017 · 233 citations · Full text

, , +9

Isolated P-selectin Glycoprotein Ligand-1 Dynamic Adhesion to P- and E-selectin

Douglas J. Goetz, Daniel M. Greif, Han Ting Ding et al. · The Journal of Cell Biology · 1997 · 147 citations · Full text

, , +17

Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adducts

Kenneth M. Comess, Judith N. Burstyn, JohnM. Essigmann et al. · Biochemistry · 1992 · 137 citations

, , +15

The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity

Kenneth D. Bromberg, Taylor R. H. Mitchell, Anup K. Upadhyay et al. · Nature Chemical Biology · 2017 · 130 citations · Full text

, , +11

1–5 of 24